The evaluation of γ-H2AX levels may not only allow for the monitoring of the efficiency of anticancer treatment but also predict tumor cell sensitivity to DNA damaging anticancer agents and toxicity of anticancer treatment toward normal cells [44]. Here, H2AX is linked to neoplasm.